Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 12 open reading frame 54 (C12orf54) encodes a 127-amino acid protein predicted to have post-translational modifications such as phosphorylation and predicted to reside in both nucleus and cytoplasm due to a nuclear export signal. The protein is ubiquitously expressed, though more highly in testes, yet its specific biochemical function remains unknown. It contains a domain of unknown function (DUF4681), has several aliases (notably HSD-29 and HSD-30), and appears evolutionarily conserved in mammals but is not associated with known diseases, therapeutic targeting, drug interactions, or safety concerns. This information is consistent across several key biological databases, and there are no established scientific errors or warnings associated with this gene entry.
Not applicable; no drugs targeting this molecule are listed
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 12 open reading frame 54 (C12orf54).